Marking International Women’s Day, American Oncology Institute (AOI),  a leading network of cancer care hospitals with over 13 years of presence in India and treating more than 1.3 million patients annually, has announced the launch of NYLA – Let This Be About Her, an initiative aimed at strengthening awareness and preventive care for cancers affecting women. The initiative focuses on encouraging regular screenings, early diagnosis, and preventive healthcare practices for cancers such as breast, cervical, ovarian, and uterine cancers, which remain among the most common cancers affecting women globally. In India, breast cancer accounts for nearly 28–30 per cent of all cancers among women, highlighting the urgent need to promote early detection and timely medical intervention.

The name NYLA, derived from Sanskrit, means “winner,” reflecting AOI’s belief that every woman deserves the knowledge and support needed to take charge of her health. While awareness around women’s health has improved in recent years, screening uptake and preventive vaccination remain relatively low, particularly for cervical cancer, where early screening and HPV vaccination can play a critical role. As part of the rollout, the NYLA program will be implemented across AOI centres in Jammu, Jalandhar, Ludhiana, Hisar, Gurugram, Sri Ganganagar, Kota, Aligarh, Raipur, Imphal, Nagpur, Hyderabad, Vijayawada, Guntur, and Coimbatore, enabling wider access to awareness, screening support, and expert oncology guidance.

The initiative will leverage AOI’s integrated oncology capabilities to strengthen both early detection and treatment pathways. Through awareness initiatives, clinical consultations, and structured screening guidance, the program aims to encourage early diagnosis of cancers affecting women. Patients requiring treatment will have access to AOI’s comprehensive oncology services, including medical oncology, surgical oncology, radiation oncology, and advanced therapies such as brachytherapy, enabling evidence-based and multidisciplinary cancer care.

Commenting on the initiative, Dileep Mangsuli, Chairman of Cancer Treatment Services International (CTSI), said "At CTSI, our vision is to elevate healthcare standards globally by expanding access to high-quality cancer care and preventive health services. The launch of NYLA reflects this commitment, as we work towards empowering women with greater awareness and access to early detection for cancers such as breast, cervical, ovarian, and uterine cancer. With a strong focus on Tier 2 and Tier 3 cities across India, we are committed to enabling wider screening and early diagnosis, ensuring that women, irrespective of where they live and have access to timely care. By encouraging preventive screenings and early intervention, we aim to support women in taking proactive steps towards safeguarding their health."

Highlighting the importance of preventive healthcare, Faisal Siddiqui, Vice President & COO – Processes, CTSI South Asia, added "Strengthening awareness around preventive healthcare and encouraging timely screening is essential to improving cancer screening. Through NYLA, we are working to expand awareness and facilitate structured screening pathways so that women can seek early medical evaluation. Enabling access to the right guidance at the right time is critical to ensuring cancers are identified earlier and managed more effectively.”

Emphasising the role of early detection, Dr. Vibhor Gupta, Medical Director – Oncology Business, American Oncology Institute, said "A significant proportion of women’s cancers, particularly breast, cervical, ovarian, and uterine cancers, can be effectively managed when diagnosed at an early stage. Structured screening protocols, clinical evaluation, and timely diagnostic interventions play a critical role in identifying malignancies before they progress to advanced stages.”